The main activities of the "PharmaDiall" company are search, development, chemical synthesis, "in vitro" and "in vivo" testing, organization and performing the clinical trials (all phases) and patenting of new biologically active chemicals that can later turn into drugs.
Dmitry G. Tovbin, Dmitry N. Tarasov, Dmitry V. Malakhov, Natalia A. Tserkovnikova, Arseniy V. Aybush, Natalia N. Drozd
Curr Drug Discov Technol. 2021 Feb 23.
The Development of New Low-Molecular-Weight Factor Xa Inhibitors That Are Potential Anticoagulants
We have obtained results for the 3rd group of volunteers in the 1st phase of clinical trials of the Amidine hydrochloride dosage form (DD217). Number of volunteers - 6 people. Administration - 60 mg once, orally. Preliminary results - serious adverse events haven’t been observed.